Xolegel Related Published Studies
Well-designed clinical trials related to Xolegel (Ketoconazole Topical)
Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. [2011.07]
Synergistic effects of tetrandrine on the antifungal activity of topical
ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011]
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. [2010.03.01]
Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study. [2008.11]
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. [2007.10]
Well-designed clinical trials possibly related to Xolegel (Ketoconazole Topical)
Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection. [2009.04]
Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. [2007.08]
Other research related to Xolegel (Ketoconazole Topical)
Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011.07]
Investigating effect of microemulsion components: In vitro permeation of ketoconazole. [2011.06]
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in
orabase in treatment of Candida-infected denture stomatitis. [2010]
An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2009]
Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits. [2008.10]
An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2008.08.01]
Ketoconazole: a review of a workhorse antifungal molecule with a focus on new foam and gel formulations. [2008.05]
Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide. [2008]
Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole. [2008]
The role of ketoconazole in seborrheic dermatitis. [2007.10]
Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor. [2007.07]
A new ketoconazole topical gel formulation in seborrhoeic dermatitis: an updated review of the mechanism. [2007.06]
Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis. [2007.06]
In vitro activity of an ear rinse containing tromethamine, EDTA, benzyl alcohol and 0.1% ketoconazole on Malassezia organisms from dogs with otitis externa. [2007.04]
Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study. [2007.03]
Comparison of different perrmeation enhancers on topical ketoconazole formulations. [2007]
Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial. [2006.07]
SLN and NLC for topical delivery of ketoconazole. [2005.08]
Topical application of ketoconazole stimulates hair growth in C3H/HeN mice. [2005.04]
Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences. [2005.03]
Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis. [2004.12]
Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. [2004.09]
Use of oral ketoconazole to prevent postoperative erections following penile surgery. [2004.08]
Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole. [2004.06]
Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. [2004.02.01]
Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. [2003]
Fluconazole versus ketoconazole in the treatment of tinea versicolor. [2002.06]
Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. [2002.04]
A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. [2002]
A case of confluent and reticulated papillomatosis responsive to ketoconazole cream. [2002]
Euclidean and fractal computer-assisted corneofungimetry: a comparison of 2% ketoconazole and 1% terbinafine topical formulations. [2002]
Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. [2001.06]
Systemic ketoconazole for yeast allergic patients with atopic dermatitis. [2001.01]
[Major eosinophilia in a premature infant induced by topical ketoconazole] [2000.04]
Successful treatment of tinea capitis with 2% ketoconazole shampoo. [2000.04]
Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. [2000.03]
Topical treatment of dermatophytosis and cutaneous candidosis with flutrimazole 1% cream: double-blind, randomized comparative trial with ketoconazole 2% cream. [1999]
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. [1998.12]
Oral ketoconazole in cutaneous fungal infections. [1998.06]
Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin. [1998]
Effect of ketoconazole 2% shampoo on scalp sebum level in patients with seborrhoeic dermatitis. [1997.03]
Comparison of single dose 400 mg versus 10-day 200 mg daily dose ketoconazole in the treatment of tinea versicolor. [1997.01]
A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. [1997.01]
[Oxiconazole cream versus ketoconazole cream. A prospective, randomized, double-blind, multicenter study in the treatment of inguinocrural dermatophytoses] [1996]
The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole. [1995.09]
Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole. [1994.07]
In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum. [1994.01]
Tinea nigra: treatment with topical ketoconazole. [1993.10]
Topical ketoconazole does not potentiate oral cyclosporin A in allergic contact dermatitis. [1992.08]
Intraocular penetration of ketoconazole in rabbits. [1992.07]
Evaluation of topical ketoconazole in cutaneous leishmaniasis. [1992.01]
Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults. [1992]
The antiinflammatory effects of ketoconazole. A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs. [1991.08]
[Treatment of seborrhoeic eczema with ketoconazole in comparison with an active agent-free cream] [1991.08]
[Transcutaneous absorption of ketoconazole in infant after application of Ketoderm] [1991.01]
A prospective study to assess the efficacy of ketoconazole in the treatment of recurrent vaginal candidiasis. [1990.09.17]
Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole. [1990.03]
Topical ketoconazole for infantile seborrhoeic dermatitis. [1990]
Ketoconazole in the treatment of blepharitis. [1990]
[A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor] [1990]
A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. [1989.09]
Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study. [1988.11]
Clinical pharmacokinetics of ketoconazole. [1988.01]
Experimental intravitreal ketoconazole in DMSO. [1988]
Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis. [1987.10]
Other possibly related research studies
Otomycosis: clinical features and treatment implications. [2006.11]
Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature. [2006]
Confluent and reticulated papillomatosis : a review of the literature. [2006]
[Use of topical antifungal agents] [2006.05]
Treatment of tinea capitis caused by Microsporum ferrugineum with itraconazole. [2005.11]
The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents. [2006.05]
Aureobasidium pullulans keratitis. [2006.04]
Acanthamoeba keratitis in a 5-year-old boy without a history of contact lens usage. [2006.04]
What is the best way to treat tinea cruris? [2006.03]
Fungal infections of the skin: infection process and antimycotic therapy. [2005.12]
Hyperkeratotic head and neck Malassezia dermatosis. [2006]
Antifungal susceptibility and genetic similarity of sequential isolates of Trichophyton rubrum from an immunocompetent patient with chronic dermatophytosis. [2006.01]
Clinical status of agents being developed for leishmaniasis. [2005.11]
Endophthalmitis caused by Fusarium proliferatum. [2005.10]
Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis. [2006.07]
[Malassezia species in patients with seborrheic dermatitis and atopic dermatitis] [2005]
Management of cryptococcosis in non-HIV-related patients. [2005.05]
A novel foam vehicle for delivery of topical corticosteroids. [2005.07]
Clinical treatment of corneal infection due to Fonsecaea pedrosoi--case report. [2005.03]
Transient band-like keratopathy after treatment for seborrheic dermatitis. [2005.04]
[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology] [2004]
Topical therapy for fungal infections. [2004]
Role of antifungal agents in the treatment of seborrheic dermatitis. [2004]
Pimecrolimus-induced tinea incognito. [2004.11]
Treatment of confluent and reticulated papillomatosis with azithromycin. [2004.08]
Influence of human nail etching for the assessment of topical onychomycosis therapies. [2004.09.10]
Pharmacologic management of pattern hair loss. [2004.05]
[Lithium] [2004.03]
New treatments for tinea capitis. [2004.04]
|